Remote-controlled Capsule Endoscopy: a Feasibility Study

Status Recruiting

Clinical Trial Summary

The present study is a feasibility study to assess the safety and efficacy of wireless capsule endoscope and compare the data obtained with those obtained by using a conventional esophagogastroduodenoscopy.

The product was developed and manufacture in China.(the NaviCam. AKC-1.China)

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01946633
Study type	Interventional
Source	Nanfang Hospital of Southern Medical University
Contact	xinying Wang, Associate Professor
Phone	86-020-61541540
Email	sunwingwxy@163.com
Status	Recruiting
Phase	N/A
Start date	October 2013

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05518929` - Hypoxia During Gastroenterological Endoscope Procedures Sedated With Ciprofol In Overweight Or Obesity Patients	Phase 4
Completed	`NCT03291418` - To Compare the Gastrointestinal Safety of a 14-Day Oral Dosing Regimen of ATB-346 to Sodium Naproxen in Healthy Subjects	Phase 1/Phase 2
Not yet recruiting	`NCT05526339` - HFNO Combined With NPA Reduces Hypoxia During Sedated Gastrointestinal Endoscopy In Obese Patients	N/A
Completed	`NCT01435525` - Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation	N/A
Completed	`NCT00527787` - Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) Naproxen	Phase 3
Completed	`NCT01129011` - Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) Naproxen	Phase 3
Terminated	`NCT00594854` - Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers in High Risk Subjects Compared to Arthrotec	Phase 3
Recruiting	`NCT05517408` - Dose Exploration of Ciprofol for Sedation in Gastrointestinal Endoscopic Diagnosis and Treatment of Obese Patients.	N/A
Completed	`NCT01964131` - BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male Subjects	Phase 1
Completed	`NCT01150162` - Mucosta in Gastric Ulcer Treatment, Effectiveness and Safety Evaluation	Phase 3
Recruiting	`NCT01037491` - Comparison of Ulcer Healing in Patients Taking Rabeprazole With Different Antiplatelets	N/A
Completed	`NCT00961350` - A Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers	Phase 3
Completed	`NCT00960869` - Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers	Phase 3
Completed	`NCT00595517` - Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer	Phase 3
Completed	`NCT00428701` - An Open-label, Exploratory Trial to Assess Gastric Acid Control in Critically Ill Subjects Receiving Nexium	Phase 4
Completed	`NCT01452711` - Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Gastric Ulcer	Phase 3
Terminated	`NCT05579444` - Systems Biology of Gastrointestinal and Related Diseases
Completed	`NCT02761512` - Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Gastric Ulcer	Phase 3
Recruiting	`NCT03057171` - A Study on the Gastrointestinal Disease and Helicobacter Pylori Controlled Long Non-coding RNA
Completed	`NCT01568398` - A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Low-Dose Aspirin Therapy	Phase 3